Thank you
This live web event has ended. Thank you for attending.
Description
Multimodal pain therapy can result in additive or synergistic analgesic effects and minimize adverse drug effects, especially in the perioperative timeframe. The goal of this Virtual Roundtable Discussion is to support interaction among experts and health professionals. Experts in this session can address your questions related to both perioperative pain as well as persistent postoperative pain that may cause long-term disability. In order to facilitate a meaningful dialogue, this Virtual Roundtable Discussion is limited to no more than 15 attendees. Submit your cases/questions for discussion prior to the Roundtable by emailing them to jwestlund@painmed.org.
Please note CME will not be offered for this session.
Objectives
At the conclusion of this session, participants will be better able to:
1) Discuss multimodal pain therapy can result in additive or synergistic analgesic effects and minimize adverse drug effects, especially in the perioperative timeframe.
2) Support interaction among experts and health professionals.
3) Discuss questions related to both perioperative pain as well as persistent postoperative pain that may cause long-term disability.
About PCSS and Funding for this Program
This virtual roundtable event is part of the
Providers Clinical Support System (PCSS.) PCSS is a program funded by the
Substance Abuse and Mental Health Services Administration (SAMHSA) created in
response to the opioid overdose epidemic to train primary care providers in the
evidence-based prevention and treatment of opioid use disorders and treatment
of chronic pain. PCSS is made up of a coalition, led by American Academy of
Addiction Psychiatry (AAAP), of major healthcare organizations (including AAPM)
all dedicated to addressing this healthcare crisis. Through a variety of
trainings and a clinical coaching program, PCSS’s mission is to increase
healthcare providers’ knowledge and skills in the prevention, identification,
and treatment of substance use disorders with a focus on opioid use disorders.
Funding for this initiative was made possible
(in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The
views expressed in written conference materials or publications and by speakers
and moderators do not necessarily reflect the official policies of the
Department of Health and Human Services; nor does mention of trade names,
commercial practices, or organizations imply endorsement by the U.S.
Government.
For more information visit: www.pcssnow.org. For questions email: pcss@aaap.org